PharmaCielo Ltd. (PCLOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0365
+0.0001 (4.29%)
May 27, 2025, 9:30 AM EDT
PharmaCielo Revenue
In the year 2024, PharmaCielo had annual revenue of 3.48M CAD with 125.70% growth. PharmaCielo had revenue of 1.13M in the quarter ending December 31, 2024, with 361.82% growth.
Revenue
3.48M CAD
Revenue Growth
+125.70%
P/S Ratio
2.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.78M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.48M | 1.94M | 125.70% |
| Dec 31, 2023 | 1.54M | -3.77M | -70.96% |
| Dec 31, 2022 | 5.31M | 3.36M | 172.93% |
| Dec 31, 2021 | 1.94M | -708.92K | -26.71% |
| Dec 31, 2020 | 2.65M | 1.87M | 237.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jul 31, 2017 | Pro | Pro | Pro |
| Jul 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
PharmaCielo News
- 3 months ago - PharmaCielo Reports Q4 2024 Financial Results - Newsfile Corp
- 3 months ago - PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing - Newsfile Corp
- 6 months ago - PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025 - Benzinga
- 6 months ago - PharmaCielo Reports Q3 2024 Financial Results - Newsfile Corp
- 7 months ago - PharmaCielo Announces Intention to Extend Expiry Date of Warrants - Newsfile Corp
- 7 months ago - Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify - Benzinga
- 8 months ago - PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024 - Newsfile Corp
- 10 months ago - PharmaCielo GAAP EPS of -C$0.015, revenue of C$0.78M - Seeking Alpha